Bhaskar C. Das
17Patents
1h-index
18Co-inventors
47Inventor score
Filing activity: Jan 27, 2009 → Mar 2, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10766886B2 | Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof | Physics | 1 | Active |
| US8460635B2 | Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents | Chemistry; Metallurgy | 1 | Active |
| US10189827B2 | Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof | Physics | 1 | Active |
| US9346835B2 | Compositions and methods for improving glucose uptake | Chemistry; Metallurgy | 1 | Active |
| US9512092B2 | Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof | Physics | 1 | Active |
| US11591324B2 | Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof | Physics | 0 | Active |
| US12269803B2 | Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease | Chemistry; Metallurgy | 0 | Active |
| US10669266B2 | Oxadiazole inhibitors of HIPK2 for treating kidney fibrosis | Chemistry; Metallurgy | 0 | Active |
| US10450305B2 | LKB1-AMPK activators for therapeutic use in polycystic kidney disease | Chemistry; Metallurgy | 0 | Active |
| US10047107B2 | Small molecule analogs of E4orf1 | Chemistry; Metallurgy | 0 | Active |
| US11643394B2 | Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease | Chemistry; Metallurgy | 0 | Active |
| US8669260B2 | Ketoconazole-derivative antagonist of human pregnane X receptor and uses thereof | Human Necessities | 0 | Active |
| US9714259B2 | Compositions and methods for improving glucose uptake | Chemistry; Metallurgy | 0 | Active |
| US12378235B2 | HCK inhibitors for the treatment of fibrosis and cancer | Chemistry; Metallurgy | 0 | Active |
| US8581005B2 | Mitochondrial inhibitors to treat human disease | Physics | 0 | Active |
| US10174012B2 | LKB1-AMPK activators for therapeutic use in polycystic kidney disease | Chemistry; Metallurgy | 0 | Active |
| US9469659B2 | Compositions and methods for improving glucose uptake | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.